Patrick Marcellin
Top Publications Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection (2011) – 2,403 citations Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus (1998) – 2,336 citations Regression of cirrhosis during treatment ... <a title="Patrick Marcellin" class="read-more" href="https://journalsworld.com/researchers/patrick-marcellin/" aria-label="Read more about Patrick Marcellin">Read more</a>
Read biography ↓Biography, research & contributions
Top Publications
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection (2011) - 2,403 citations
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus (1998) - 2,336 citations
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study (2012) - 1,808 citations
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection (2014) - 1,718 citations
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection (2011) - 1,630 citations
At a glance
- Full name
- Patrick Marcellin
- ORCID
- 0000-0001-8950-0287
- OpenAlex ID
- https://openalex.org/A5013246678
Research interests
- Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Animal Virus Infections Studies, Liver physiology and pathology
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection ↗2011 · New England Journal of Medicine2,403OpenAlex citations
- 2,336OpenAlex citations
- 1,808OpenAlex citations
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection ↗2014 · New England Journal of Medicine1,718OpenAlex citations
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection ↗2011 · New England Journal of Medicine1,630OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection ↗2011 · New England Journal of Medicine
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection ↗2014 · New England Journal of Medicine
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection ↗2011 · New England Journal of Medicine
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 21:55:35
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.